Evidence map›Paper›PMID 36417653›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2022

Temporal progression of sepsis on critical care COVID-19 patients: a retrospective cohort study.

Petrus Lee, Fernanda Bordignon Nunes, Jorge Amilton Höher, Gisele Branchini

Abstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Petrus LeeUniversidade Federal de Ciências da Saúde de Porto Alegre, Graduate Program in Pathology - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0002-7491-7212
Fernanda Bordignon NunesUniversidade Federal de Ciências da Saúde de Porto Alegre, Graduate Program in Pathology - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0003-1028-7490
Jorge Amilton HöherSanta Casa de Misericórdia de Porto Alegre, Department of Critical Care - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0003-1091-8248
Gisele BranchiniUniversidade Federal de Ciências da Saúde de Porto Alegre, Graduate Program in Pathology - Porto Alegre (RS), Brazil.ORCID http://orcid.org/0000-0003-2524-8603

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to describe sepsis progression in critical COVID-19 patients using the SOFA score and investigate its relationship with mortality.

methodsThree researchers collected and analyzed retrospective clinical and laboratory data found in electronic health records from all patients admitted to a severe COVID-19 exclusive intensive care unit from March 2020 to October 2020. Mixed-effect logistic regression was used to evaluate SOFA (Sepsis-3) score variables as mortality prediction markers, while Kaplan-Meier survival curves were used to compare mortality between groups of patients. Cox proportional hazard models were used to further stratify mortality association between variants.

resultsA total of 73 patients were included. Temporal COVID-19-related sepsis progression analysis indicates difference in degrees and timing between different organ dysfunction over time. Sepsis-3 Cardiovascular Dysfunction characterized by severe hypotension added to the use of any vasopressor drugs was the only parameter associated with in-hospital death during the first 5 days of hospital admission (OR 2.19; 95%CI 1.14-4.20; p=0.01).

conclusionIncreased Sepsis-3 Cardiovascular Dysfunction score, characterized as hypotension associated with the use of vasopressor drugs in the first days of intensive care unit stay, is related to higher mortality in COVID-19 patients and may be a useful prognostic prediction tool.

Indexed as

COVID-19HypotensionSepsisCritical CareHospital MortalityHumansRetrospective Studies

Identifiers

PMID36417653
PMCPMC9683908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.